Alembic Pharmaceuticals Ltd has received final approval from the US Food and Drug Administration for prazosin hydrochloride capsules USP in 1 mg, 2 mg, and 5 mg strengths, the company said in an exchange filing.
The drug is a generic version of Pfizer Inc's Minipress capsules.
It is indicated for the treatment of hypertension to lower blood pressure.
According to data by IQVIA, the drug had sales of approximately $50 mln for the 12-month period ended December.
Ailing Hospitals Part 5: No MRI, Shared Beds, Poor Lighting - Problems Galore At Mumbai's Nair Hospital
Maharashtra: Over 200 Cattle Markets Affected As Qureshi Community Protests Vigilante Action Against Traders
Government Pledges Transparent Subsidy Transfers For Domestic LPG Consumers
Maharashtra Politics: Former MLA Rahul Mote Joins Ajit Pawar's NCP With Supporters
Shares of the company traded 0.8% lower at ₹521.05 on the NSE, at 09:15 IST.
